MedVasc
MedVasc has developed an instrument for a safer, less painfuland more cost-effective treatment of varicose veins. Varicose vein disease affects 25-30% of the population worldwide. More serious cases often require surgical treatment and although the technique is refined, the procedure is often painful to the patient. The solution developed by MedVasc is a patent-protected medical instrument, which delivers pain free local anaesthesia. This means that the patient does not need further sedative or pain relief treatment and can go home immediately after treatment.
In 2018, MedVasc completed a prototype and established a partnership with ARAN, a leading Israeli product design and development firm.
MedVasc
Patented instrument for quicker and moreeffectivetreatmentofvaricoseveins.
Founded by Dr Michael Åkesson.
Portffolio company since 2017.
Portfolio Manager LU Holding:
christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), phone +46 70 928 63 78